Evidence map›Paper›PMID 32458270›Full record

ReviewLa Radiologia medica2021

MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature.

Marco Varrassi, Antonella Corridore, Emanuele Tommasino, Giorgia Saltelli, Federico Bruno, Alessandra Di Sibio, Alessandra Splendiani, Ernesto Di Cesare, Carlo Masciocchi

Erratum issuedAbstract readReview
PubMed Publisher
In one paragraph

Review in La Radiologia medica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Rosai-Dorfman disease of the cauda equina: illustrative case.Journal of neurosurgery. Case lessons · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rosai-Dorfman disease: a differential diagnosis to consider in dural-based masses.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marco VarrassiRadiology Department, Ospedale "San Salvatore", Via L. Natali 1, 67100, L'Aquila, Italy.
Antonella CorridoreDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy.
Emanuele TommasinoDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy. emanuele.tommasino@gmail.com.ORCID http://orcid.org/0000-0003-1523-8081
Giorgia SaltelliAnesthesiology and Intensive Care, Department of Surgical and Medical Science and Translational Medicine, University "La Sapienza", Rome, Italy.
Federico BrunoDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy.
Alessandra Di SibioRadiology Department, Ospedale "San Salvatore", Via L. Natali 1, 67100, L'Aquila, Italy.
Alessandra SplendianiDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy.
Ernesto Di CesareDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy.
Carlo MasciocchiDepartment of Biotechnological and Applied Clinical Science, University of L'Aquila AQ, Via Vetoio 1 AQ, 67100, L'Aquila, Italy.
University of L'Aquila · ITSan Salvatore Hospital · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosai-Dorfman disease (RDD) is a rare, benign, non-Langerhans cells histiocytosis with massive lymphadenopathy of uncertain aetiology. It is commonly characterized by massive, painless, non-tender, bilateral cervical lymphadenopathy. Extra-nodal involvement is usually seen in 50% of patients, with the brain being affected in only 5% of cases, usually as dural-based lesions. Clinical presentation is heterogeneous and strongly dependent on the localization of the lesions. Although the histopathological findings are essential for the final diagnosis, brain magnetic resonance imaging (MRI) currently represents the first-line strategy for the detection of the lesions across the central nervous system (CNS); moreover, it may provide additional elements for the differential diagnosis versus other more common lesions. We performed a case-based literature review to highlight possible aetiologic and pathogenetic theories of this disease, along with imaging features of RDD, with a particular focus on the MRI characteristics of the CNS involvement (CNS-RDD). Finally, we provided a novel insight on the current therapeutic approaches, either surgical or medical.

Indexed as

Magnetic Resonance ImagingAdultAgedContrast MediaDiagnosis, DifferentialHistiocytosis, SinusHumansImaging, Three-DimensionalIopamidolMaleMiddle AgedRetrospective StudiesTomography, X-Ray ComputedContrast MediaiomeprolIopamidolMRIRDDRosai–Dorfman diseaseSpectroscopy

Identifiers

PMID32458270
OpenAlexW3029509038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.